Market Value421,480,000
Total Holdings89
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
XENE / Xenon Pharmaceuticals Inc.
PRDS / Pardes Biosciences Inc
DRNA / Dicerna Pharmaceuticals Inc
/ Pandion Therapeutics Inc
US750469AA69 / Radius Health, Inc. Bond
SCPH / scPharmaceuticals Inc.
US55027E1029 / Luminex Corporation
SAVA / Cassava Sciences, Inc.
US0906721065 / BioTelemetry, Inc.
US74140Y1010 / Prevail Therapeutics Inc.
US00771VAB45 / Aerie Pharmaceuticals Inc
RDUS / Radius Recycling, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
AGTC / Applied Genetic Technologies Corp
LQDA / Liquidia Corporation
MASI / Masimo Corporation
SPPI / Spectrum Pharmaceuticals, Inc.
CFMS / Conformis Inc.
LRMR / Larimar Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
JNJ / Johnson & Johnson
IFRX / InflaRx N.V.
TBIO / Telesis Bio, Inc.
KNTE / Kinnate Biopharma Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
MRUS / Merus N.V.
BHVN / Biohaven Ltd.
CBAY / CymaBay Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
KDMN / Kadmon Holdings Inc
US2103731061 / Constellation Pharmaceuticals Inc
LCTX / Lineage Cell Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
GMTX / Gemini Therapeutics Inc
ALPN / Alpine Immune Sciences, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
VERO / Venus Concept Inc.
TBPH / Theravance Biopharma, Inc.
MEIP / MEI Pharma, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ARNA / Arena Pharmaceuticals Inc
NRIX / Nurix Therapeutics, Inc.
AERI / Aerie Pharmaceuticals Inc
TPTX / Turning Point Therapeutics Inc
HOOK / HOOKIPA Pharma Inc.
ISEE / IVERIC bio Inc
NXTC / NextCure, Inc.
ATHA / Athira Pharma, Inc.
NTUS / Natus Medical Inc
HARP / Harpoon Therapeutics, Inc.
PLX / Protalix BioTherapeutics, Inc.
INFI / Infinity Pharmaceuticals Inc.
ETNB / 89bio, Inc.
FATE / Fate Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
CSII / Cardiovascular Systems Inc.
APLS / Apellis Pharmaceuticals, Inc.
MORF / Morphic Holding, Inc.
OTIC / Otonomy Inc
BLUE / bluebird bio, Inc.
CARA / Cara Therapeutics, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
NGM / NGM Biopharmaceuticals, Inc.
GNFT / Genfit S.A.
AFMD / Affimed N.V.
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
RIGL / Rigel Pharmaceuticals, Inc.
SCYX / SCYNEXIS, Inc.
ALEC / Alector, Inc.
ATRC / AtriCure, Inc.
KRTX / Karuna Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
MRSN / Mersana Therapeutics, Inc.
ACET / Adicet Bio, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
STRO / Sutro Biopharma, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
CGEN / Compugen Ltd.
INGN / Inogen, Inc.
RCUS / Arcus Biosciences, Inc.
STIM / Neuronetics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
SAGE / Sage Therapeutics, Inc.
ARAY / Accuray Incorporated
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
VKTX / Viking Therapeutics, Inc.
KURA / Kura Oncology, Inc.
DXCM / DexCom, Inc.
STXS / Stereotaxis, Inc.
PRQR / ProQR Therapeutics N.V.